Back to Studies
P1107 / Cord Blood Transplantation
Cord Blood Transplantation with CCR5delta32 Donor Cells in Persons Living with HIV who Require Bone Marrow Transplantation for any Indication and Its Observed Effects on HIV-1 Persistence
Study Status
Closed to Accrual
DAIDS Number
11883
IND Number
Non-IND
Clinical Trials Link
Primary Protocol Team Members
Summary
P1107 is multi-center observational study that will describe the outcomes of up to 25 participants from the US living with HIV, ages 12 months and older, who undergo transplantation with CCR5Δ32 cord blood stem cells for treatment of cancer, hematopoietic disease, or other underlying disease.
15 February 2022: IMPAACT P1107 Team Presents First Known Case of a Woman with HIV Remission
>> Learn More
Loading study documents...
Loading study sites...
Loading study protocol team...
Loading study press...
Loading study publications/presentations...